Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Clinics ; 69(supl.1): 22-27, 1/2014. graf
Article in English | LILACS | ID: lil-699023

ABSTRACT

The Japanese ABO-Incompatible Transplantation Committee officially collected and analyzed data on pediatric ABO-incompatible living-donor kidney transplantation in July 2012. The age of a child was defined as <16 years, and 89 children who had undergone ABO-incompatible living-donor kidney transplantation from 1989 to 2011 were entered in a registry. These data were presented as the Japanese registry of pediatric ABO-incompatible living-donor kidney transplantation at the regional meetings of the International Pediatric Transplantation Association (IPTA) in Nagoya in September 2012 and in Sao Paulo in November 2012.


Subject(s)
Adolescent , Adult , Child , Female , Humans , Male , Middle Aged , ABO Blood-Group System/blood , Blood Group Incompatibility/blood , Kidney Transplantation/mortality , Living Donors/statistics & numerical data , Blood Group Incompatibility/complications , Blood Group Incompatibility/mortality , Graft Rejection , Graft Survival , Japan/epidemiology , Kidney Transplantation/adverse effects , Kidney Transplantation/statistics & numerical data , Plasmapheresis , Retrospective Studies , Survival Rate
2.
Medicina (Ribeiräo Preto) ; 26(4): 567-79, out.-dez. 1993. tab
Article in Portuguese | LILACS | ID: lil-129973

ABSTRACT

As transfusöes de hemoderivados apresentam um risco de 20por ciento de produzirem uma reaçäo adversa para o receptor. Entre estas reaçöes, as mais importantes säo a transmissäo de doenças como a hepatite e AIDS, as reaçöes transfusionais hemolíticas e a alossensibilizaçäo dos receptores. Nesta revisäo säo discutidas as principais reaçöes adversas às transfusöes sanguíneas e as medidas a serem tomadas para a sua prevençäo e tratamento.


Subject(s)
Humans , Pregnancy , Infant, Newborn , Adult , Communicable Disease Control , Communicable Diseases/mortality , Blood Group Incompatibility/mortality , Signs in Homeopathy , Symptomatology , Blood Transfusion/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL